(S)-3-(2-Nitrophenoxy)pyrrolidine hydrochloride, 95.0%, 1g

Mevastatin, >95%, 1g

N-Boc-2-(2-amino-ethoxy)-ethylamine hydrochloride, 98.0%, 250mg

5-Amino-2-(hydroxymethyl)phenylboronic Acid Cyclic Monoester>95.0%(HPLC)(T)1g

2-Fluoro-6-methoxybenzoic acid, 99.0%, 25g

2,6-Bis(4-azidobenzylidene)cyclohexanone (wetted with ca. 30% Water) (unit weight on dry weight basis) [Research for Photosensitive Material]>85.0%(HPLC)25g

1-(5-Bromoindolin-1-yl)ethanone, 95.0%, 25g

2,5-Dihydroxybenzoic Acid Sodium Salt>98.0%(HPLC)(T)25g

2-Amino-5-nitrobenzotrifluoride, 98.0%, 25g

N,N'-Bis(salicylidene)-1,2-propanediamine>98.0%(GC)(T)5g

2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one, 97.0%, 250mg

1-Pyrrolidino-1-cyclopentene>97.0%(GC)25g

(5-(Hydroxymethyl)pyridin-3-yl)boronic acid, 95.0%, 250mg